Olink Holding AB (publ)
OLK
Rangering i aksjer
#4809
Olink Holding AB (publ) offers a comprehensive suite of products and services... Olink Holding AB (publ) offers a comprehensive suite of products and services tailored for life science research institutions, including academic bodies, government entities, biopharmaceutical companies, and biotechnology firms. The company's product lines include Olink Explore, which is designed to aid research in critical areas such as cardiovascular and metabolic health, oncology, neurology, and inflammation. Additionally, it features the Olink Target product line and the Olink Focus product line, the latter providing bespoke solutions for clients who have already pinpointed specific proteins or protein signatures for their studies. Beyond these, Olink supplies the Signature Q100, a dedicated platform for qPCR (quantitative Polymerase Chain Reaction) readouts. Its service portfolio encompasses Olink Analysis, offering end-to-end support from study design and expert consultation to sample preparation, assay execution, and stringent quality control of data, complemented by bioinformatics services. For data management and analysis, Olink provides the normalized protein expression (NPX) Manager, a specialized software tool enabling users to import data, validate its quality, and normalize findings in preparation for statistical analysis. Furthermore, Olink Insight serves as a cloud-based platform for visualizing and statistically analyzing NPX data. Olink Holding AB (publ) markets and sells its offerings worldwide through its proprietary direct sales force, reaching customers across the Americas, Europe, the Middle East, Africa, and the Asia Pacific region. Established in 2004 and based in Uppsala, Sweden, the company underwent a name change in January 2021 from its former identity, Knilo HoldCo AB, to its current designation. It operates as a subsidiary of Summa Equity Holding AB.
Aksjekurs
$26.08
Sist synkronisert: 2024-07-09
Markedsverdi
$3.10B
Endring (1 dag)
0.31%
Endring (1 år)
0.00%
Land
SE
Handel Olink Holding AB (publ) (OLK)
Kategori
Healthcare
Antall utestående aksjer for Olink Holding AB (publ) (OLK)
Antall utestående aksjer per March 2024: 124.34M
Ifølge Olink Holding AB (publ) sine siste økonomiske rapporter og aksjekurs er antall utestående aksjer nå 124.34M. Ved slutten av December 2022 hadde selskapet 119.08M utestående aksjer. Antallet utestående aksjer påvirkes vanligvis av aksjesplitt og tilbakekjøp.
Historikk over utestående aksjer for Olink Holding AB (publ) (OLK) fra 2019 til 2026
Utestående aksjer ved utgangen av hvert år
| År | Utestående aksjer | Endre |
|---|---|---|
| 2026 (TTM) | 124.34M | 0.28% |
| 2023 | 124.00M | 4.14% |
| 2022 | 119.08M | 19.96% |
| 2021 | 99.26M | -16.59% |
| 2020 | 119.01M | 0.00% |
| 2019 | 119.01M | 0.00% |
Utestående aksjer for lignende selskaper eller konkurrenter
| Selskap | Utestående aksjer | Forskjell | Land |
|---|---|---|---|
| 371.00M | 198.37% |
US
|
|
| 705.30M | 467.22% |
US
|
|
| 143.28M | 15.23% |
US
|
|
| - | - |
CN
|
|
| 282.00M | 126.79% |
US
|
